Newsroom
Saniona Icon blue
Latest News
August 25, 2022
Three Months Ended June 30, 2022 (2021) Six Months Ended June 30, 2022 (2021) Revenue was SEK 3.0 M (1.9 M) Revenue was SEK 9.6 M (5.3 M) Operating profit/loss was SEK -91.8 M (-103.6 M) Net profit/loss was SEK -88.6 M (-103.9 M) Operating profit/loss was SEK -225.0 M (-197.7 M) Net profit/loss was
August 18, 2022
PRESS RELEASE August 18 , 202 2 Today, on August 18 , 2022, an extraordinary general meeting was held in Saniona AB . A summary of the adopted resolution follows below. The resolution w as adopted with the required majority of vot es. Resolution on (A) employee option program ; and (B) directed
August 16, 2022
PRESS RELEASE August 16 , 202 2 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that it ha s progressed its promising Kv7 epilepsy program into the Lead Optimization Phase , which is the last drug discovery phase before potential selection of a clinical candidat
If you have any questions regarding Saniona's media communication, feel free to contact us at any time.
thomas feldthus
Thomas Feldthus, co-founder and CEO Email: investor@saniona.com